Editor of Patient Care Online.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 15, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Arthritis in Older Adults: Patient Thoughts on Symptoms, Management, & Clinician Counseling
New findings from a national survey shed light on patient attitudes and experiences with arthritis and joint pain.
Urban Areas in US are Associated with Lower Rates of Hypertension Medication Adherence, New Study Finds
AHA Hypertension 2022: New research showed that hypertension medication adherence was nearly 76% in large urban areas and increased as population density decreased.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 13, 2022
Two-thirds of Older Adults with Arthritis Use OTC Treatments, yet Many Do not Consult with Clinician about Medication Risks
Findings from the University of Michigan National Poll on Healthy Aging highlight the need for clinicians to raise the topic of joint pain with their older patients.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 12, 2022
Abelacimab Receives Fast Track Designation from FDA for Prevention of Stroke, Systemic Embolism in Patients with Atrial Fibrillation
Abelacimab is a dual-acting, fully human monoclonal antibody that selectively targets both factor XI and factor XIa with high affinity.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 9, 2022
COVID-19 Bivalent Booster Shot Q&A for Clinicians
Get answers to 7 questions you may have regarding bivalent booster dose vaccination for patients from the US Centers for Disease Control and Prevention.
DASH Diet May Prevent Nearly 27 000 US CVD Events in Patients with Stage 1 Hypertension, According to Simulation Study
AHA Hypertension 2022: Adoption of the DASH diet was found to prevent an estimated 16 000 CVD events among men and 11 000 among women with untreated stage 1 HTN.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 8, 2022
COVID-19 mRNA Vaccines Found Safe in Patients with Heart Failure in Real-world Study
ESC 2022: SARS-CoV-2 mRNA vaccines were not associated with an increased risk of worsening heart failure, venous thromboembolism, or myocarditis in a large Danish real-world study.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 7, 2022
Hypertension Awareness and Control Improved with Better Access to Primary Care, New Study Finds
Regardless of where individuals live, they may benefit from blood pressure control programs that increase access to primary health care, study authors suggest.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 6, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 2, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 31, 2022
Primary Care Month in Review: 6 Popular Stories from August 2022
Use of exercise trackers associated with improved physical activity, FDA recommends repeat at-home COVID-19 antigen testing, and 4 more top content from August.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 30, 2022
Specific Blood Pressure Thresholds Not Needed When Selecting Patients with T2D for Antihypertensive Treatment, Suggests New Research
Blood pressure-lowering therapy reduced the risk of major CV events in persons with and without type 2 diabetes, according to an individual participant-level data meta-analysis.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 29, 2022
Primary Viewpoints Episode 18: Why Humor Can be the Best Medicine for Clinicians
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Ernest R. Gelb, DO, 126th president of the American Osteopathic Association.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 26, 2022
Study Analyzing Efficacy of Nonhormonal Contraceptive Gel, Phexxi, for Prevention of Chlamydia, Gonorrhea Completes Last Subject Last Visit
Top-line data from the EVOGUARD clinical trial examining the efficacy of Phexxi for the prevention of chlamydia and gonorrhea are expected in October 2022.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 25, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 24, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 23, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 22, 2022
New Real-world Study Finds Average Length of COVID-19 Infectiousness is 5 Days
A new real-world study found that two-thirds of patients with COVID-19 were still infectious 5 days and one-fourth at 7 days after symptom onset.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 19, 2022